222 related articles for article (PubMed ID: 29886317)
1. Evaluation of NovaSure
Philip CA; Le Mitouard M; Maillet L; de Saint-Hilaire P; Huissoud C; Cortet M; Dubernard G
Eur J Obstet Gynecol Reprod Biol; 2018 Aug; 227():46-51. PubMed ID: 29886317
[TBL] [Abstract][Full Text] [Related]
2. [Clinical efficacy of NovaSure for 30 patients with adenomyosis].
Li D; Wan Y; Mu Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 41(1):88-92. PubMed ID: 26819431
[TBL] [Abstract][Full Text] [Related]
3. Effect of undiagnosed deep adenomyosis after failed NovaSure endometrial ablation.
Mengerink BB; van der Wurff AA; ter Haar JF; van Rooij IA; Pijnenborg JM
J Minim Invasive Gynecol; 2015 Feb; 22(2):239-44. PubMed ID: 25460320
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Combined Bipolar Radiofrequency Impedance-Controlled Endometrial Ablation with Levonorgestrel Intrauterine System versus Bipolar Radiofrequency Endometrial Ablation Alone in Women with Abnormal Uterine Bleeding.
Zhao H; Yang B; Feng L; Li H; Shang H; Zhao Z; Dai Y
J Minim Invasive Gynecol; 2020; 27(3):774-780. PubMed ID: 31201942
[TBL] [Abstract][Full Text] [Related]
5. Hysteroscopic rollerball endometrial ablation as an alternative treatment for adenomyosis with menorrhagia and/or dysmenorrhea.
Preutthipan S; Herabutya Y
J Obstet Gynaecol Res; 2010 Oct; 36(5):1031-6. PubMed ID: 20846253
[TBL] [Abstract][Full Text] [Related]
6. Combination of microwave endometrial ablation and postoperative dienogest administration is effective for treating symptomatic adenomyosis.
Ota K; Takahashi T; Shiraishi S; Mizunuma H
J Obstet Gynaecol Res; 2018 Sep; 44(9):1787-1792. PubMed ID: 29998482
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of endometrectomy by radiofrequency for premenopausal women: a retrospective study].
Maillet L; de Saint-Hilaire P; Rudigoz RC; Dubernard G
J Gynecol Obstet Biol Reprod (Paris); 2013 Sep; 42(5):458-63. PubMed ID: 23790970
[TBL] [Abstract][Full Text] [Related]
8. Endometrial Ablation in Women With Abnormal Uterine Bleeding Related to Ovulatory Dysfunction: A Cohort Study.
Hokenstad AN; El-Nashar SA; Khan Z; Hopkins MR; Famuyide AO
J Minim Invasive Gynecol; 2015; 22(7):1225-30. PubMed ID: 26149205
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives.
Miller JD; Lenhart GM; Bonafede MM; Basinski CM; Lukes AS; Troeger KA
Int J Womens Health; 2015; 7():59-73. PubMed ID: 25610002
[TBL] [Abstract][Full Text] [Related]
10. [The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis].
Lou J; Huang X; Zhang L; Xu P; Zhang X; Chen Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 48(2):136-141. PubMed ID: 31309750
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of endometrial ablation for treating abnormal uterine bleeding in pre- and postmenopausal women with liver cirrhosis.
Liu Q; Li XL; Liu JJ; Song XH; Jiang XY; Li W; Zhang H; Pan CQ
J Obstet Gynaecol Res; 2016 Dec; 42(12):1753-1760. PubMed ID: 27647778
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Long-Term NovaSure Endometrial Ablation Failure.
Lybol C; van der Coelen S; Hamelink A; Bartelink LR; Nieboer TE
J Minim Invasive Gynecol; 2018; 25(7):1255-1259. PubMed ID: 29550389
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative Predictors of Long-term Outcomes After Radiofrequency Endometrial Ablation.
Shazly SA; Famuyide AO; El-Nashar SA; Breitkopf DM; Hopkins MR; Laughlin-Tommaso SK
J Minim Invasive Gynecol; 2016; 23(4):582-9. PubMed ID: 26867699
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the NovaSure endometrial ablation procedure in women with uterine cavity length over 10 cm.
Thiel JA; Briggs MM; Pohlman S; Rattray D
J Obstet Gynaecol Can; 2014 Jun; 36(6):491-497. PubMed ID: 24927186
[TBL] [Abstract][Full Text] [Related]
15. Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation.
Xie H; Wan Y; Yi S; Zeng F; Sun X; Yang Y; Xiao S
Int J Gynaecol Obstet; 2022 Aug; 158(2):301-307. PubMed ID: 34653258
[TBL] [Abstract][Full Text] [Related]
16. Heat can treat: long-term follow-up results after uterine-sparing treatment of adenomyosis with radiofrequency thermal ablation in 60 hysterectomy candidate patients.
Stepniewska AK; Baggio S; Clarizia R; Bruni F; Roviglione G; Ceccarello M; Manzone M; Guerriero M; Ceccaroni M
Surg Endosc; 2022 Aug; 36(8):5803-5811. PubMed ID: 35024930
[TBL] [Abstract][Full Text] [Related]
17. Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion.
Kang L; Gong J; Cheng Z; Dai H; Liping H
J Minim Invasive Gynecol; 2009; 16(2):169-73. PubMed ID: 19249704
[TBL] [Abstract][Full Text] [Related]
18. Histologic findings in hysterectomies after endometrial ablation.
Karpathiou G; Chauleur C; Dal Col P; Dridi M; Laville D; Mobarki M; Peoc'h M
Pathol Res Pract; 2020 Aug; 216(8):152992. PubMed ID: 32475645
[TBL] [Abstract][Full Text] [Related]
19. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
Sabbah R; Desaulniers G
J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
[TBL] [Abstract][Full Text] [Related]
20. Endometrial ablation with the NovaSure system in Iran.
Asgari Z; Moini A; Samiee H; Tehranian A; Mozafar-Jalali S; Sabet S
Int J Gynaecol Obstet; 2011 Jul; 114(1):73-5. PubMed ID: 21507403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
